van Akkooi ACJ. Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know? Ann Surg Oncol 2023 Oct 16. doi: 10.1245/s10434-023-14416.
PMID: 37843663